Filing Details
- Accession Number:
- 0001600620-23-000022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-23 17:19:49
- Reporting Period:
- 2023-05-18
- Accepted Time:
- 2023-05-23 17:19:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1600620 | Aurinia Pharmaceuticals Inc. | AUPH | Pharmaceutical Preparations (2834) | 981231763 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1838242 | R.w. David Jayne | #140, 14315 ? 118 Avenue Edmonton A0 T5L 4S6 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-05-18 | 8,733 | $0.00 | 48,733 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-05-19 | 9,310 | $0.00 | 58,043 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2023-05-23 | 8,733 | $11.26 | 49,310 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2023-05-18 | 8,733 | $0.00 | 8,733 | $0.00 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2023-05-19 | 15,234 | $0.00 | 15,234 | $10.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-05-18 | No | 4 | M | Direct | |
| 15,234 | 2033-05-19 | No | 4 | A | Direct |
Footnotes
- Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date.
- Represents grant of the RSUs payable solely in common stock of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.
- The option vests in twelve equal monthly installments commencing on June 19, 2023.
Billionaire Hedge Funds
